ConocoPhillips vs NOV Inc. — Stock Comparison
Q·Score Breakdown
6.5
Neutral
Overall
4.9
Bearish
Quality
Health
Growth
Valuation
Sentiment
COP
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ revenue declining 5% year-over-year.
NOV
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ revenue declining 2% year-over-year.
Analyst Consensus
BUY
Target $140.37 (+13.9%)
27 analysts
HOLD
Target $21.10 (+6.2%)
20 analysts
Fundamentals
COP
NOV
20.9×
Trailing P/E
79.4×
14.5×
Forward P/E
14.8×
12.3%
Profit Margin
1.0%
45.6%
Gross Margin
20.6%
11.3%
ROE
1.5%
-5.3%
Revenue Growth
-2.4%
-20.2%
Earnings Growth
-73.7%
0.19
Beta
0.94
—
Price / Book
—
$150.1B
Market Cap
$7.1B
$84 – $136
52-Week Range
$12 – $21
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →